Aquisição de FREMANEZUMAB SC 225MG/1,5ML SOL INJ CAN, ao abrigo do CPA 2023/436, para a ULSASI, para o ano 2024

ID 10850191 · Portal BASE
Price
Base Price
€72,317 .00
Effective Price
€72,317 .00 0.0%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ao abrigo de acordo-quadro (art.º 259.º)
CPV Code
33600000
Location
Portugal, Lisboa, Amadora
Bidder Count
—
Winner
TEVA PHARMA - PRODUTOS FARMACÊUTICOS LDA
NIF 507045491
Company
Dates
Publication
01 Aug 2024
Celebration
25 Jul 2024
Contracting Entity
HOSPITAL PROFESSOR DOUTOR FERNANDO FONSECA, EPE
NIF 503035416
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 35 · MEDIUM RISK
A5 · Threshold Splitting
A5_THRESHOLD_SPLITTING
MEDIUM
Base price
72317.0
Threshold
75000.0
Rule
A5 threshold splitting: price within 5% below 75000.0
Detected 2026-03-06